LENZ Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
LENZ Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • LENZ Therapeutics, Inc. Depreciation for the quarter ending December 31, 2023 was $100K, a 85.7% decline year-over-year.
  • LENZ Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2023 was $2.4M, unchanged year-over-year.
  • LENZ Therapeutics, Inc. annual Depreciation for 2023 was $2.4M, unchanged from 2022.
  • LENZ Therapeutics, Inc. annual Depreciation for 2022 was $2.4M, a 243% increase from 2021.
  • LENZ Therapeutics, Inc. annual Depreciation for 2021 was $700K, a 600% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.4M $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.4M +$1.7M +243% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $700K +$600K +600% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-21
2020 $100K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.